Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,477 Cr₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹1,477 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,477 Cr
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr
Mar2021₹937 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹1,477 Cr
-5.24
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,804.4 Cr 6.1% -10.6% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹105,961.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -4.6% -7% 1.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

6.1%

-10.6%

-2.1%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses